Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
These are fundamentally different conditions with different causes and different prognoses
The drug is delivered in once-weekly subcutaneous injections and is currently indicated for use in patients with type 2 diabetes
It requires a daily injection but may still be appropriate for patients who are not candidates for newer agents or who need a different insurance access pathway
This content was produced in connection with a marketing arrangement with MEDVi
If you choose to use MT-2, start with low doses, monitor your skin carefully, get regular dermatologist checks, and stay honest with yourself about the risk-benefit tradeoff
US$ 20.71
US$ 27.40
US$ 29.88
US$ 26.90
